Category: 340B
-
STAT+: Minnesota report shows large hospitals continue to dominate the 340B drug discount program
STAT+: Minnesota report shows large hospitals continue to dominate the 340B drug discount program Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in revenue in 2024, and the largest institutions were the biggest beneficiaries, according to a report from the state Department of Health. Specifically, hospitals…
-
STAT+: J&J suffers a loss over 340B drug discount program
STAT+: J&J suffers a loss over 340B drug discount program In a setback to Johnson & Johnson, a federal judge ruled that a U.S. government agency did not violate the law when it required the company to seek approval before offering rebates to hospitals and clinics that participate in a drug discount program. The decision…